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Abstract     
Background: While standardized diagnostic interviews using established criteria are the 
gold standard for assessing depression, less time consuming measures of depression and 
depressive symptoms are commonly used in large population health surveys. We examine 
the prevalence and health-related correlates of three depression measures among adults 
aged 18-79 years in Germany. 
Methods: Using cross-sectional data from the national German Health Interview and 
Examination Survey for Adults (DEGS1) (n=7987) and its mental health module (DEGS1-
MH) (n=4483), we analysed prevalence and socio-demographic and health-related correlates 
of a) major depressive disorder (MDD) established by Composite International Diagnostic 
Interview (CIDI) using DSM-IV-TR criteria (CIDI-MDD) in the last 12 months, b) self-reported 
physician or psychotherapist diagnosed depression in the last 12 months, and c) current 
depressive symptoms in the last two weeks (PHQ-9, score ≥10).  
Results: Prevalence of 12-month CIDI-MDD was 4.2% in men and 9.9% in women. 
Prevalence of 12-month self-reported health professional-diagnosed depression was 3.8% 
and 8.1% and of current depressive symptoms 6.1% and 10.2% in men and women, 
respectively. Case-overlap between measures was only moderate (32-45%). In adjusted 
multivariable analyses, depression according to all three measures was associated with 
lower self-rated health, lower physical and social functioning, higher somatic comorbidity 
(except for women with 12-month CIDI-MDD), more sick leave and higher health service 
utilization. 
Limitations: Persons with severe depression may be underrepresented. Associations 
between CIDI-MDD and correlates and overlap with other measures may be underestimated 
due to time lag between DEGS1 and DEGS1-MH. 
Conclusions: Prevalence and identified cases varied between these three depression 
measures, but all measures were consistently associated with a wide range of adverse 
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CIDI   Composite International Diagnostic Interview 
DSM-IV Diagnostic and Statistical Manual of Mental Disorders, 4th edition 
DSM-IV-TR Diagnostic and Statistical Manual of Mental Disorders, 4th edition, text revision 
DEGS1 German Health Interview and Examination Survey for Adults (DEGS1) 
DEGS1-MH Mental health module of DEGS1  
MDD  Major depressive disorder 
PHQ-9  Patient Health Questionnaire nine item depression scale 







Depression is one of the most common mental disorders and a leading cause of years of life 
lost due to disability and disease burden worldwide (Ferrari et al., 2013; Murray et al., 2012; 
Whiteford et al., 2013; Wittchen et al., 2011). Reliable data on the prevalence and 
consequences of depression in the general population are needed to estimate disease 
burden, inform healthcare policy and develop preventive strategies. 
A key challenge in obtaining reliable population estimates of depression arises from how the 
term depression is defined and used in the literature. The generic term depression is 
commonly used to describe a broad spectrum of diverse conditions which share the common 
characteristic of disturbed mood. These conditions may range from isolated depressive 
symptoms of short-duration, through dysthymia or subthreshold depressive disorders, to 
major depressive disorders with variable severity and duration (American Psychiatric 
Association, 2013; Angst and Merikangas, 1997; Ayuso-Mateos et al., 2010). Accordingly, 
measurement instruments range from simple self-rating scales to screen for current 
depressive symptoms without differential diagnosis, such as the Patient Health 
Questionnaire nine-item depression scale (PHQ-9) (Kroenke et al., 2001; Löwe et al., 2002), 
to fully-structured diagnostic interviews such as the World Health Organisation (WHO) 
Composite International Diagnostic Interview (CIDI) (Kessler et al., 1998) to assess for major 
depressive disorder (MDD) using the Diagnostic and Statistical Manual of Mental Disorders 
(DSM) (American Psychiatric Association, 2013) criteria. In addition to these different 
approaches, population surveys in the US (Reeves et al., 2011), Canada (Betancourt et al., 
2014), Germany (Busch et al., 2013; Buttery et al., 2014; Maske et al., 2014) and other 
countries frequently employ questions about the history of health professional-diagnosed 
depression to capture the reality of clinical practice and the communication of depression 
diagnosis experienced by respondents.   
CIDI-defined major depression is the gold standard for estimating the burden of clinical 
depression in general populations (Haro et al., 2006; Wittchen et al., 1998). However, due to 
6 
 
time constraints or specific research objectives, shorter and simpler measures are commonly 
used in health surveys and general population samples. For example, sub-threshold 
depressive symptoms are important to measure from a public health perspective as they are 
associated with functional impairment (Rapaport et al., 2002) and other adverse health 
outcomes (Rodriguez et al., 2012).  
The aim of this study is to provide up-to-date information on the burden of depression in the 
general adult population in Germany by considering three different measures of depression. 
We examine the prevalence of MDD according to DSM-IV-TR criteria in the last 12 months 
as assessed by CIDI interview, self-reported physician- or psychotherapist-diagnosed 
depression in the last 12 months and current depressive symptoms in the last two weeks 
(PHQ-9 score) in a nationwide population-based study of adults aged 18-79 years. As these 
three measures must be clearly distinguished with regard to the underlying construct and the 
time frame, Table 1 shows an overview of their main features.  Associations of all three 
measures with a range of socio-demographic characteristics and health-related correlates, 
including self-rated health, somatic comorbidity, indicators of impairment and functioning and 





Study design and sample 
The German Health Interview and Examination Survey for Adults (DEGS1, field work 2008-
2011) and its mental health module (DEGS1-MH, field work 2009-2012) were conducted to 
obtain comprehensive information about the health of the non-institutionalized population 
aged 18-79 years in Germany. The design, objectives and methods of DEGS1 and DEGS1-
MH have been described in detail elsewhere (Gößwald et al., 2013; Jacobi et al., 2015; 
Jacobi et al., 2013; Kamtsiuris et al., 2013; Scheidt-Nave et al., 2012). In brief, a random 
sample of persons aged 18 to 79 years stratified for sex, age and geographical location was 
selected using two-stage clustered random sampling (stage 1: 180 sample points from all 
German municipal communities; stage 2: participants from local population registries of those 
sample points) and supplemented by former participants of the previous German National 
Health Interview and Examination Survey 1998 (Kamtsiuris et al., 2013; Scheidt-Nave et al., 
2012). For DEGS1-MH, all DEGS1 participants with complete assessment (interview and 
examinations) aged 18 to 79 years were eligible who had consented to being re-contacted 
for the mental health module, who had sufficient language skills and who were available 
during the assessment period (Jacobi et al., 2015; Jacobi et al., 2013).  
In DEGS1, data was collected by self-administered written questionnaire, standardized 
physician-administered computer-assisted personal interview (CAPI) and a range of physical, 
laboratory and other measurements. In DEGS1-MH, in-depth information on mental 
disorders including MDD was collected by a fully-structured standardized computer-assisted 
interview (CIDI). The median time lag between DEGS1 and DEGS1-MH was 6 weeks 
(interquartile range, 5-25 weeks).  
DEGS1 was approved by the federal and state commissioners for data protection and by the 
ethics committee of Charité-Universitätsmedizin Berlin (No. EA2/047/08). DEGS1-MH was 
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additionally approved by the ethics committee of the Technische Universität Dresden (No. 
EK174062009). All participants provided written informed consent prior to interview.  
 
Measures of depression 
MDD in the last 12 months based on diagnostic criteria of the DSM-IV-TR was assessed in 
DEGS1-MH with a modified German version of the CIDI (DIA-X/M-CIDI) (Jacobi et al., 2013; 
Wittchen and Pfister, 1997). The CIDI is an internationally established, standardized 
computer-assisted psychiatric interview for the assessment of 12-month and lifetime 
diagnoses of mental disorders using the diagnostic criteria of the DSM-IV (Kessler and 
Ustun, 2004; Wittchen, 1994; Wittchen et al., 1998). A diagnosis of CIDI-MDD in the last 12 
months (12-month CIDI-MDD) is based on the nine DSM-IV-TR symptoms (criterion A), 
which are assessed with 30 single questions. CIDI-MDD is defined as the presence of at 
least five of the nine depression symptoms, of which at least one is depressed mood or 
decreased interest or pleasure on almost every day for most of the time over a period of two 
weeks or longer during the last 12 months. MDD diagnosis also requires distress or 
impairment associated with these symptoms (DSM-IV criterion C) and absence of DSM-IV 
exclusion criteria which are: 1) symptoms due to physical illness, injury or accident, 2) 
symptoms due to medication, drugs or alcohol, 3) symptoms are explained by grief, and 4) 
lifetime manic or hypomanic episodes. 
Self-reported health professional-diagnosed and communicated depression was defined as a 
previous diagnosis of depression made by a physician or psychotherapist within the last 12 
months. In the physician-administered CAPI participants were asked: “Have you ever been 
diagnosed with depression by a physician or a psychotherapist?” and, if affirmed, “Was the 
depression present during the last 12 months?” (Busch et al., 2013). 
Current depressive symptoms were assessed with the self-administered German version of 
the PHQ-9 (Kroenke et al., 2001; Löwe et al., 2002), which measures the presence and 
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frequency within the last two weeks of the nine DSM-IV symptoms for depressive disorders 
(DSM-IV criterion A). Based on reported frequencies of symptoms, scores of 0 ("not at all "), 
1 ("several days"), 2 ("more than half the days") or 3 ("nearly every day") points are assigned 
to each item.  Scores for individual items are summed (range 0 - 27 points). A score of 10 or 
more points indicates current depressive symptoms (Kroenke et al., 2001; Löwe et al., 2002). 
 
Other measures 
In DEGS1, socio-demographic variables included age, sex and marital status (dichotomized 
into married and living with partner versus separated, divorced, widowed or single). Self-
perceived levels of social support were assessed using the Oslo-3 Social Support Scale 
(OSS-3) and categorized as poor (3–8 points), moderate (9–11 points) and strong support 
(12–14 points) (Dalgard et al., 2006). Socio-economic status (SES) was classified as low, 
middle and high using an index based on information on education, occupational status and 
net household income (Lampert et al., 2013). Community size was determined based on 
official administrative municipal codes for the place of residence and categorized into rural 
(<5,000 inhabitants), small town (5,000 to <20,000 inhabitants), medium-sized town (20,000 
to <100,000) and large town (≥100,000 inhabitants) (Kamtsiuris et al., 2013). 
Self-rated health was measured using the first question of the German version of the Short 
Form 36 (SF-36 version 2) (Ellert and Kurth, 2013; Ware, 2000) and dichotomized as poor or 
fair versus good, very good, or excellent. 
Self-reported physician-diagnosed chronic somatic conditions were assessed in DEGS 1 by 
the CAPI and included lifetime diagnoses of coronary heart disease (CHD) (myocardial 
infarction or other CHD), stroke, heart failure, chronic renal disease, cirrhosis of the liver, 
osteoarthritis, osteoporosis, Parkinson's disease and cancer. In addition, the presence of 
hypertension, diabetes, dyslipidaemia, epilepsy, rheumatoid arthritis, gout, bronchial asthma, 
hepatitis, gastric-duodenal ulcer and inflammatory bowel disease in the last 12 months was 
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recorded. The total number of physician-diagnosed conditions (range 0-19) was grouped into 
none, one, and two or more chronic somatic conditions. 
Physical functioning (PF) and social functioning (SF) were assessed in DEGS1 using SF-36 
sub-scales (Ellert and Kurth, 2013; Ware, 2000). Established methods were used to calculate 
PF and SF scores (range 0-100), with higher values indicating better functioning (Ellert and 
Kurth, 2013; Ware JEJ et al., 2007). 
In DEGS1-MH, the number of days with limitations in daily life activities due to physical or 
mental health problems in the past four weeks was assessed. Participants were asked on 
how many days during the past four weeks they were a) totally limited and b) at least mildly 
limited in daily life activities by physical or mental health problems. The total number of 
activity limitation days was calculated by summing the numbers of days with total limitation 
(counted as 1) and mild limitation (counted as 0.5). The total number of days was truncated 
at a maximum of 28 days. 
The number of sick leave days from work in the last 12 months was assessed in DEGS1 
among participants younger than 65 years in employment by self-administered 
questionnaire.  
Healthcare use was recorded in DEGS1 by self-reports of any episodes of hospital 
admission for at least one night in the last 12 months and the number of outpatient visits to 
any primary care or specialist physician in the last 12 months. 
 
Statistical analysis 
All analyses were conducted for men and women separately. The prevalence of CIDI-MDD in 
the last 12 months, self-reported health professional-diagnosed depression in the last 12 
months and current depressive symptoms were calculated as percentages with 95% 
confidence intervals (95% CI) of the total number of men and women with valid data. 
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Participants with missing data on the three depression measures were excluded from 
respective analyses. Prevalence was stratified by socio-demographic characteristics. 
Differences in prevalence were considered statistically significant if 95% CI did not overlap. 
The percentage of case-overlap for the three measures was calculated as formal 
concordance and agreement analyses between the three depression measures were not 
considered appropriate due to conceptual differences between the measures (clinical MDD, 
self-reported health professional-diagnosed depression, current depressive symptoms) and 
the different time frames used in their assessment (12 months versus two weeks).  
Associations between the three depression measures (dependent variables) and SES and 
community size (independent variables) were examined with multiple logistic regression 
analyses adjusting for age, marital status, social support and the number of chronic somatic 
conditions (and community size and SES, respectively). Participants with missing data on 
covariables were excluded from further analyses of associations. 
Associations between health-related correlates (dependent variables) and the three 
depression measures (independent variables) were examined using a variety of regression 
methods. Logistic regression models were used for binary outcome variables (poor/fair self-
rated health; any sick leave days in the last 12 months; any hospital admission in the last 12 
months; any activity limitation day in the last four weeks). Linear regression models were 
used for continuous outcome variables (SF-36 PF and SF scales). Multinomial logistic 
regression was used for the number of chronic somatic conditions. For count outcome 
variables, negative binomial regression was used without (number of outpatient physician 
visits) or with zero-inflation (number of sick leave days; number of activity limitation days) 
based on testing for zero-inflation with the Vuong test. Regression analyses were adjusted 
for age, SES, marital status, social support, number of chronic somatic conditions (except in 
analyses on the number of chronic conditions), and physical functioning (except in analyses 
on the number of chronic conditions, PF and SF).  
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In sensitivity analyses, we examined the influence of time lag between DEGS1 and DEGS1-
MH on the association between CIDI-MDD and correlates assessed in DEGS1 by including 
interaction terms of CIDI-MDD and the number of weeks between examinations in quartiles 
into relevant regression models. Additionally, the number of weeks of time lag between 
examinations was included as a covariable in separate models. No significant interactions 
were found and the inclusion of time lag did not materially change effect estimates (detailed 
results not reported).  
All analyses were conducted with a weighting factor which accounts for the complex 
sampling design and which corrects deviations in the sample from the population structure 
(as of 31 Dec 2010) with regard to age group, sex, region and nationality, as well as 
community type and education (Kamtsiuris et al., 2013). For all analyses using the DEGS1-
MH subsample, a similar weighting factor was calculated which additionally accounts for 
eligibility and participation in DEGS1-MH (Jacobi et al., 2013). To take into account the 
weighting as well as the correlation of participants within a community, confidence intervals 






 DEGS1 comprised a total of 7987 participants aged 18 to 79 years (4198 women, 3789 
men). Among those with complete assessment (n=7115), 6027 fulfilled the inclusion criteria 
for DEGS1-MH and of these, 4483 participated in DEGS1-MH with full psychiatric 
assessment with the CIDI (2340 women, 2143 men). Table 2 shows characteristics of 
DEGS1 and DEGS1-MH participants by sex. Compared to men, women were less likely to 
have high SES, had lower levels of physical and social functioning, reported higher numbers 
of activity limitation days due to physical or mental health problems in the last four weeks and 
reported higher numbers of outpatient physician visits in the last 12 months. 
 
Prevalence of CIDI-MDD, self-reported diagnosed depression and current depressive 
symptoms 
Of 7987 DEGS1 participants, 3583 men (94.6%) and 3940 women (93.9%) had valid data on 
current depressive symptoms, and 3757 men (99.2%) and 4142 women (98.7%) had valid 
data on self-reported health professional-diagnosed depression in the last 12 months. Of 
4483 DEGS1-MH participants, 2103 men (98.1%) and 2305 women (98.5%) had valid data 
on 12-month CIDI-MDD.  
Table 3 shows the prevalence of all three depression measures by socio-demographic 
characteristics. For all measures, a significantly higher prevalence was found among women. 
Prevalence of 12-month CIDI-MDD, self-reported health professional-diagnosed depression 
in the last 12 months and current depressive symptoms was 4.2%, 3.8% and 6.1% in men 
and 9.9%, 8.1% and 10.2%, respectively, in women.  
Of those participants with CIDI-MDD in DEGS1-MH, 33.0% had self-reported health 
professional-diagnosed depression and 39.3% had current depressive symptoms in DEGS1. 
Of those with self-reported health professional-diagnosed depression in DEGS1, 45.1% had 
current depressive symptoms and 37.2% had CIDI-MDD in DEGS1-MH. Of those with 
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current depressive symptoms in DEGS1, 31.9% had self-reported health professional-
diagnosed depression and 32.4% had CIDI-MDD in DEGS1-MH. 
Prevalence established by all three measures varied by age but there was no consistent age-
related pattern across measures. In both sexes, current depressive symptoms were most 
prevalent in the age group 18-34 years and decreased thereafter. Prevalence of CIDI-MDD 
in women was also highest in those aged 18-34 years, while in men it was highest in those 
aged 45-54. For both measures, confidence intervals of prevalence estimates overlapped 
widely across age groups. By contrast, the prevalence of self-reported health professional-
diagnosed depression was lowest among men and women aged 18-34 years, then rose and 
peaked in the 55-64 year age group and subsequently declined. This peak in late middle age 
was more pronounced and statistically significant among women. 
Prevalence of all three measures in women and of self-reported health professional-
diagnosed depression in men was significantly higher among those who were not married 
and living with partner compared to those married and living together. There was also a 
significant relationship between poor social support and higher prevalence across the three 
measures in both sexes, albeit weaker in men than in women.  
 
Association with socio-economic status and community size 
Table 4 shows the results of adjusted logistic regression models examining the associations 
between SES and community size and the three measures. There were no significant 
associations between SES or community size and CIDI-MDD. Low SES was associated with 
significantly higher odds of self-reported health professional-diagnosed depression for 
women and current depressive symptoms for both men and women. With regard to 
community size, men living in mid-sized or large towns had significantly higher odds of self-
reported health professional-diagnosed depression compared to those living in small towns. 
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Table 5 shows the results of adjusted regression analyses examining the associations 
between the three depression measures and health-related correlates.  
The odds of poor/fair self-rated health was most notably increased in men (odds ratio (OR) 
8.6) and women (OR 5.3) with current depressive symptoms. Having two or more chronic 
somatic conditions was associated with CIDI-MDD among men, but no statistically significant 
relationship was found among women. However, having two or more chronic somatic 
conditions was significantly associated with self-reported health professional-diagnosed 
depression and current depressive symptoms for both men and women.  
The strength of the associations of depression according to the three measures with PF and 
SF was lower for women than for men and was comparatively lower for CIDI-MDD than the 
other two measures. CIDI-MDD was associated with increased odds of any activity limitation 
days and the number of activity limitation days in the last four weeks in men and women. 
Among participants younger than 65 years and in employment, all three measures were 
associated with a higher number of sick leave days in the last 12 months for both sexes. 
However, none of the three measures were associated with any sick leave day in men, while 
only CIDI-MDD was not associated with any sick leave days in women. Concerning health 
service utilisation, depression according to all three measures was associated with more 
outpatient physician visits (rate ratio (RR) 1.3-2.5) in the last 12 months in both sexes and 





This nationwide population-based study examined the prevalence and burden of MDD 
according to DSM-IV-TR assessed with the CIDI, self-reported health professional-diagnosed 
depression in the last 12 months and current depressive symptoms in a representative 
sample of adults aged 18-79 years in Germany. Prevalence estimates and identified cases 
varied between the three measures, but all measures were consistently associated with a 
wide range of adverse health outcomes. 
 
Prevalence of CIDI-MDD, self-reported diagnosed depression and current depressive 
symptoms 
We found that the total prevalence of CIDI-MDD was similar to the prevalence of self-
reported health professional-diagnosed depression among men (4.2% vs. 3.8%) and only 
slightly higher among women (9.9% vs. 8.1%). However, the notably different patterns of 
prevalence across age groups and the moderate case-overlap (33% of CIDI-MDD reported 
health professional-diagnosed depression and 37% of health professional-diagnosed 
depression had CIDI-MDD) highlights that these measures identify different depression 
cases. The divergence may be explained by the different concepts underpinning the 
measures. CIDI-MDD assesses the presence of diagnostic criteria according to the DSM-IV-
TR in the last 12 months, while self-reported health professional-diagnosed depression relies 
on several assumptions. These include: 1) the diagnosis was correct, 2) the health 
professional informed the person of the diagnosis or applied treatment (Wittchen et al., 
2000b), 3) the person remembered the diagnosis at the survey interview and 4) the person 
informed the interviewer of the diagnosis, who might not do so due to fear of stigmatization 
(Schomerus and Angermeyer, 2008). Diagnosis of depression in routine clinical care in 
Germany is commonly based on ICD-10 criteria, which has a slightly lower threshold (4 instead 
of 5 symptoms required) than DSM-IV-TR- based CIDI-MDD. Findings from a meta-analysis 
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investigating general practitioner (GP) diagnosis rates in primary care indicate that these 
health professionals may be good at ruling out depression in most people who are not 
depressed but correctly diagnose depression less frequently (Mitchell et al., 2009). 
Prevalence of current depressive symptoms (PHQ-9 ≥10) was highest for both men (6.1%) 
and women (10.2%) compared to the other two measures, but more pronounced in men than 
in women.  Even though the PHQ-9 refers to the briefer time frame of two weeks, this high 
prevalence is not unexpected, as it covers sub-threshold depressive symptoms; does not 
require the presence of any of the two core symptoms of depression (depressed mood or 
loss of interest or pleasure); and does not allow for differential diagnosis (e.g. bipolar 
disorder) or the exclusion of normal bereavement. Therefore, the PHQ-9 is likely to identify 
more participants as cases than the other two measures.  
The 12-month prevalence of CIDI-MDD of 4.2% in men and 9.9% in women is comparable to 
international data on depression in western countries including the US and other Western 
countries (Kessler et al., 2015). In particular, it is similar to estimates in the National 
Comorbidity Survey Replication (NCS-R) for the general adult population in the USA (4.9% in 
men and 8.6% in women) (Kessler et al., 2003) using similar methods to measure MDD and  
to results from the DEGS1-MH predecessor study, the German National Health Interview and 
Examination Survey 1998 (GNHIES98) Mental Health Supplement (5.5% in men and 11.2% 
in women) (Jacobi et al., 2004a)). 
Our prevalence estimates for self-reported health professional-diagnosed depression (men: 
3.8%, women 8.1%) are consistent with a contemporary Germany-wide telephone survey 
reporting prevalence estimates of 4.7% in men and 8.3% in women (Buttery et al., 2014).  
However, our prevalence estimates are lower than an analysis of claims data for all people in 
Germany with statutory health insurance (about 88% of the general population) reporting a 
higher 12-month prevalence of diagnosed depression of 6.4% in men and 12.8% in women 
(Erhart and von Stillfried, 2012). Conversely, another study of  claims data including 6 Million 
people across Germany found even higher prevalence with 8.8% in men and 17.8% in 
18 
 
women (Melchior et al., 2014). However, Melchior and colleagues (2014) considered 
inpatient diagnoses in their analyses highlighting how meaningful comparisons are limited 
due to methodological differences in sample populations.   
Our estimates of current depressive symptoms are slightly higher than a previous nationwide 
population based study from Germany estimating prevalence of 5.3% in men and 8.9% in 
women using the same PHQ-9 based definition of depressive symptoms (Rief et al., 2004). 
However, differences may be due to change over time and methodological differences in the 
age range of the sample (14-93 years), and alternate statistical approaches in estimating 
prevalence. Our findings are similar to findings from the Behavioral Risk Factor Surveillance 
System (BRFSS) in the US, reporting a prevalence of 6.8% in men and 10.5% in women 
using the PHQ-8 (Strine et al., 2008). 
 
Socio-demographic correlates  
For all three measures, women had a significantly higher prevalence than men, overall and in 
specific age groups, consistent with national and international comparative studies and 
systematic reviews (Jacobi et al., 2004b; Kessler and Bromet, 2013; Reeves et al., 2011; 
Wittchen et al., 2010). A variety of bio-physiological, psychosocial and behaviour-related 
explanations have been described for these sex differences (Grigoriadis and Robinson, 
2007; Parker and Brotchie, 2010). Concerning self-reported diagnosed depression, sex-
specific help-seeking behaviour due to different extents of stigmatization and sex-specific 
reporting of symptoms should be considered as additional explanations (Hammer et al., 
2013; Latalova et al., 2014; Möller-Leimkühler, 2002). 
The prevalence according to all three measures varied with age in both men and women but 
no consistent age-related pattern was found. The prevalence of current depressive 
symptoms was highest in the youngest age group and decreased thereafter, as was the 
prevalence of CIDI-MDD in women. Among men, the prevalence of CIDI-MDD was highest in 
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the youngest age group and in those aged 45-54 years. An age-related decrease  of 
prevalence has been reported for CIDI-MDD in developed countries (Kessler et al., 2010) 
and for current depressive symptoms in the USA (Strine et al., 2008). In contrast, prevalence 
of self-reported health professional-diagnosed depression was higher in middle and older 
age groups and highest among those aged 55-64 years. This is consistent with other surveys 
from the USA (Strine et al., 2008) and Germany (Erhart and von Stillfried, 2012; Maske et al., 
2013). These age-related patterns may partly be explained by biographical influences, the 
differential impact of stress and resilience factors in different age groups, higher proportions 
of atypical types of depression that are less likely to be identified by the used measures or 
simply age-related information bias (Busch et al., 2013; Mauz and Jacobi, 2008; Wittchen et 
al., 2010). Also, age-related differences in the use of health care services may influence the 
prevalence of self-reported diagnosed depression as older people may come into contact 
with their GP due to other physical complaints (Higashi et al., 2007) and the GP may briefly 
refer to psychosocial factors (Holvast et al., 2012) thereby providing an opportunity for 
mental health assessment. Furthermore, older people may be more inclined to report that 
mental health problems have been discussed (Holvast et al., 2012) and communicate a 
diagnosis of depression to interviewers.  
Our results confirm established associations between marital status and social support and 
depression with high level of consistency across the three measures investigated (Grav et 
al., 2012; Kessler and Bromet, 2013). We found no statistically significant relationship 
between low SES and CIDI-MDD consistent with previous national data which showed trends 
in a social gradient with CIDI-MDD but no statistically significant associations in adjusted 
analyses (Jacobi et al., 2004b). However, low SES was associated with significantly higher 
odds of self-reported health professional-diagnosed depression for women and current 
depressive symptoms for both men and women. These findings are consistent with previous 
research showing that low SES is associated with an increased risk of depression and other 
mental disorders (Bromet et al., 2011; Lorant et al., 2003; World Health Organisation, 2000).  
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We found no significant association between community size and CIDI-MDD differing from 
previous studies reporting inverse relationships between urban living environment and 
mental health (McKenzie et al., 2013; Paykel et al., 2003). This may be due to alternate 
methodological approaches and how we adjusted for a larger number of important 
cofounders in our analyses than these previous studies. However, we found that men living 
in mid-sized or large towns had higher odds of self-reported health professional-diagnosed 
depression, and men and women living in mid-sized towns had significantly higher odds of 
current depressive symptoms compared to those living in small towns.  
 
Health-related correlates 
Overall, we found strong relationships between all three measures and self-rated health 
status, which is considered a valid predictor for mortality (DeSalvo et al., 2006), consistent 
with other studies in primary care settings (Ambresin et al., 2014).  
Our findings of associations between somatic comorbidity and depression are consistent with 
previous surveys of self-reported diagnosed depression for the general adult population in 
Germany (Maske et al., 2013) and depressive symptoms in primary care settings (Gunn et 
al., 2012). In the USA in the NCS-R study, associations between CIDI-MDD and having a 
higher number of somatic comorbidities were reported for the overall study population 
(Gadermann et al., 2012; Kessler et al., 2010). In our data, an association with a higher 
number of somatic comorbidities was found in men, but not in women suggesting that 
physical and mental health may be more closely aligned in men than women and highlight 
the importance of sex-specific analyses. Our analyses showed an inverse associations of all 
three measures with physical and social functioning, confirming previous associations 
between SF-36 scales and CIDI-MDD (Wittchen et al., 2000a) in the general population as 
well as with PHQ-9 measures (Martin et al., 2006). 
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In relation to sick leave and health service utilization, we found strong associations between 
the number of sick leave days in the past 12 months and all three measures. People with 
CIDI-MDD had significantly higher numbers of days with some or full impairment due to 
mental health and physical problems in the past four weeks. These findings support previous 
suggestions that depression is a substantially disabling mental disorder with regard to years 
lived with disability (Wittchen et al., 2011) and days out of usual role (Kessler and Bromet, 
2013) and has strong associations with health care utilization (Bhattarai et al., 2013). 
Research has reported a higher number of sick leave days due to common mental disorders 
for women than for men (Dietrich and Stengler, 2013), which is consistent with our results for 
current depressive symptoms and self-reported diagnosed depression among men and 
women and for CIDI-MDD among men. Furthermore, all measures were associated with 
significantly increased odds of hospital admission for men, but not in women. For CIDI-MDD, 
this gender difference may be explained by the relatively lower somatic comorbidity 
experienced by women as compared to men in our study. In general, gender-related role 
differences may also contribute to this finding, e.g. women may be less likely to receive 
inpatient therapy due to childcare responsibilities. 
 
Implications for research and clinical practice 
The results of this study emphasize the importance of specificity in depression measurement 
tools for use in both research and clinical practice for assessing, reporting and interpreting 
information about depression. Our results demonstrate that different depression measures 
identify different individuals as cases. This has implications for researchers and emphasizes 
the need for precise selection of measures of depression in clinical and population studies. 
Greater detailed description of depression measures and their specific limitations in study 
reporting is warranted from our findings. 
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In clinical practice where a rigorous diagnostic assessment is not possible due to logistic or 
time constraints, self-report assessments such as the PHQ-9 may be very useful for 
depression screening. Elevated scores should be taken seriously given the strong and 
consistent associations with many adverse health correlates found in this study and patients 
should be followed up for confirmation of diagnosis or referred for more rigorous and 
differential diagnostic assessment. 
 
Limitations  
Several methodological limitations should be considered in interpreting these findings. First, 
persons with severe depression are likely to be underrepresented in DEGS1 and DEGS1-
MH, therefore prevalence may be underestimated for all three measures. Second, the time 
lag between DEGS1 and DEGS1-MH should be considered when interpreting the results on 
CIDI-MDD and correlates from DEGS1, as this may have resulted in underestimation of 
associations. Third, even among participants with 12-month CIDI-MDD who had their 
DEGS1-MH assessment shortly after DEGS1 the last depressive episode may have been 
outside the time period of some health-related correlates (e.g., SF36-PF subscale 
investigating functioning in the previous 4 weeks) potentially resulting in an underestimation 
of respective associations. The same may apply to health professional-diagnosed 
depression. Finally, recall bias may have influenced some measures, such as self-reported 




The results presented confirm a high prevalence of 12-month CIDI-MDD, self-reported health 
professional-diagnosed depression in the last 12 months and current depressive symptoms 
in men and women in Germany and demonstrate that estimates and identified cases vary 
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widely between these three distinct measures. This has important implications for clinical 
practice and future research, highlighting the need for specificity in assessing, reporting and 
interpreting depression in populations as prevalence estimates are used to inform and impact 
on health care policy and preventive strategies. Female gender, lack of partnership and 
social support are significant correlates of depression according to all three measures 
analysed. Low SES was associated with current depressive symptoms but not 12-month 
CIDI-MDD for both men and women. Overall, depression according to all three measures 
largely demonstrated consistent associations with a wide range of adverse health outcomes 
including lower self-rated health, lower physical and social functioning, high somatic 
comorbidity (except for women with 12-month CIDI-MDD), higher number of sick leave days 
or activity limitation days (CIDI-MDD) and higher utilization of health services. These findings 
call for effectively targeted interventions to reduce the burden associated with depression 
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Table 1: Overview over the three depression measures 
Measure Method Features and areas of application 
Major depressive disorder 
according to DSM-IV-TR criteria 
Composite International 
Diagnostic Interview (CIDI)  
• Assessment: fully-structured clinical diagnostic interview (face-to-face CAPI 
interview) 
• Time frame: last 12 months 
• Gold standard for assessing 12-month MDD according to DSM-IV criteria in clinical 
and epidemiological studies 
• Allows for in-depth analyses on MDD subtypes, onset of episodes, analyses beyond 
threshold diagnosis  
• Considers diagnostic exclusions on a lifetime basis (bipolar disorder, substance-
induced depression, depression due to a general medical condition, bereavement) 
Diagnosed depression in clinical 
practice 
Self-reported depression 
diagnosis made by physician 
or psychotherapist  
• Assessment: physician-administered interview questions (face-to-face CAPI 
interview): “Has a physician or psychotherapist ever diagnosed you with 
depression?”. If the answer was yes: “Was the depression present during the past 12 
months“ 
• Time frame: last 12 months 
• Measure for health surveys about mental disorders as identified and treated in 
routine clinical care (in Germany: ICD-10 based) 
• Influenced by service utilization, severity, comorbidity and treatment status 
Current depressive symptoms 
based on DSM-IV-TR criterion A 
Patient Health Questionnaire 
nine-item depression scale  
(PHQ-9) sum score ≥10 
points 
• Assessment: self-administered questionnaire with 9 items 
• Time frame: last 2 weeks 
• Measure of current depressive symptoms in clinical and epidemiological studies and 
in health surveys 
• Brief tool for screening and measuring severity of depressive symptoms and 
syndromes in clinical practice 





Table 2 Characteristics of DEGS1 and DEGS1-MH participants by sex. Figures are weighted population estimates expressed in percent (95% 
confidence interval), unless otherwise indicated. 
 DEGS1 DEGS1-MH 







 49.7 (48.2-51.1) 50.3 (48.9-51.8) 49.2 (47.2-51.1) 50.8 (48.9-52.8) 
Age group (years)     
18-34 26.4 (24.8-28.1) 25.2 (23.6-26.8) 24.1 (21.5-26.8) 24.7 (22.6-27.0) 
35-44  18.6 (17.1-20.2) 17.7 (16.2-19.2) 18.6 (16.3-21.2) 17.9 (15.8-20.1) 
45-54  21.3 (19.9-22.7) 20.3 (18.9-21.9) 21.3 (19.1-23.6) 20.6 (18.6-22.8) 
55-64  15.6 (14.2-17.1) 15.9 (14.8-17.1) 16.0 (14.2-17.9) 15.6 (13.9-17.5) 
65-79a 18.1 (17.0-19.3) 21.0 (19.7-22.3) 20.1 (18.2-22.1) 21.2 (19.3-23.3) 
Marital status     
Married and living with partner 62.3 (59.9-64.6) 58.9 (56.7-61.1) 61.6 (58.3-64.8) 57.3 (54.1-60.4) 
Separated, divorced, widowed, or single 37.7 (35.4-40.1) 41.1 (38.9-43.3) 38.4 (35.2-41.7) 42.7 (39.6-45.9) 
Social support     
Poor 12.3 (10.9-13.9) 11.6 (10.4-12.9) 12.1 (10.0-14.4) 11.7 (9.9-13.8) 
Moderate 51.6 (49.5-53.8) 48.8 (46.9-50.7) 51.1 (48.0-54.1) 47.3 (44.5-50.2) 
Strong 36.1 (33.9-38.2) 39.6 (37.8-41.5) 36.9 (33.9-39.9) 41.0 (38.4-43.7) 
Socioeconomic status     
Low  18.8 (16.9-20.8) 20.7 (18.9-22.6) 18.7 (16.2-21.4) 20.1 (17.7-22.7) 
Middle 58.8 (56.8-60.8) 61.7 (59.7-63.7) 58.4 (55.4-61.3) 62.4 (59.2-65.4) 
High 22.4 (20.5-24.4) 17.6 (16.0-19.4) 23.0 (20.6-25.5) 17.6 (15.5-19.8) 
Community size     
Rural (< 5000 inhabitants)  16.1 (11.2-22.7) 15.9 (11.0-22.5) 15.6 (10.4-22.8) 14.5 (9.5-21.4) 
Small town (5000-<20,000)  23.4 (17.7-30.4) 23.2 (17.5-30.0) 24.0 (17.7-31.7) 24.3 (17.9-32.1) 
Mid-sized town (20,000-<100,000)  29.4 (22.9-36.8) 29.8 (23.3-37.2) 30.0 (22.9-38.2) 29.7 (22.8-37.7) 
Large town (≥100,000) 31.1 (24.4-38.7) 31.2 (24.6-38.6) 30.5 (23.5-38.5) 31.5 (24.4-39.7) 
Fair/poor self-rated health 14.5 (13.1-16.0) 16.1 (14.6-17.7) 15.4 (13.3-17.7) 17.7 (15.7-20.0) 
No. of chronic somatic conditions     
None 53.9 (51.8-55.9) 51.6 (49.7-53.5) 53.2 (50.4-56.0) 52.5 (50.0-55.0) 
1 21.4 (19.8-23.1) 22.4 (20.8-24.0) 21.0 (18.8-23.3) 20.9 (19.0-22.9) 
2+ 24.7 (23.1-26.5) 26.0 (24.5-27.6) 25.8 (23.7-28.1) 26.6 (24.5-28.9) 
SF-36 physical functioning scale, mean (95% CI) 88.8 (87.9-89.6) 84.5 (83.7-85.3) 88.9 (87.8-90.0) 84.3 (83.2-85.5) 
SF-36 social functioning scale, mean (95% CI) 88.1 (87.2-89.0) 84.0 (83.2-84.8) 88.5 (87.3-89.6) 84.1 (82.8-85.4) 
No. of activity limitation days due to physical or mental health 
problems (4 weeks), mean (95% CI) - - 2.5 (2.1-2.8) 3.4 (2.9-3.8) 
No. of sick leave days (12 months), mean (95% CI)b 10.3 (9.1-11.5) 12.3 (10.6-14.0) 11.0 (9.4-12.7) 12.6 (10.1-15.2) 
Any hospital admission (12 months) 12.4 (11.0-14.0) 13.3 (12.0-14.7) 12.2 (10.3-14.3) 13.3 (11.6-15.1) 
No. of outpatient physician visits (12 months), mean (95% CI) 6.4 (6.0-6.9) 9.2 (8.6-9.7) 6.5 (6.0-7.1) 9.2 (8.6-9.8) 
a Due to time lag between DEGS1 and DEGS1-MH (median, 6 weeks), 15 participants were already 80-81 years old at the time of DEGS1-MH assessment  
b Among participants younger than 65 years in employment (DEGS1: n=2,160 men and n=2,201 women; DEGS1-MH:  n=1,183 men and n=1,240 women)  
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Table 3 Prevalence of 12-month CIDI-defined major depressive disorder (CIDI-MDD), self-reported diagnosed depression in the last 12 months 
and current depressive symptoms (PHQ-9 ≥10) in the last 2 weeks by socio-demographic characteristics. Figures are weighted population 
estimates expressed in per cent (95% confidence interval)  
 




























Total 4.2 (3.3-5.3) 3.8 (3.1-4.7) 6.1 (5.1-7.2) 9.9 (8.3-11.9) 8.1 (7.0-9.4) 10.2 (8.9-11.5) 
Age group (years)       
18-34 4.8 (3.0-7.6) 2.7 (1.7-4.4) 7.4 (5.3-10.3) 15.7 (11.4-21.2) 6.5 (4.3-9.5) 12.0 (9.5-14.9) 
35-44  3.0 (1.4-6.4) 1.9 (0.8-4.2) 5.4 (3.6-8.2) 11.8 (7.7-17.7) 5.2 (3.5-7.7) 9.5 (7.2-12.4) 
45-54  5.8 (3.7-9.0) 5.5 (3.8-8.0) 6.0 (4.2-8.4) 8.0 (5.4-11.5) 10.1 (7.7-13.2) 9.8 (7.6-12.5) 
55-64  4.6 (2.7-7.7) 5.5 (3.7-8.3) 6.7 (4.7-9.4) 5.5 (3.5-8.5) 12.6 (9.6-16.4) 11.1 (8.3-14.6) 
65-79 2.3 (1.3-4.1) 3.9 (2.4-6.3) 4.3 (2.9-6.4) 6.8 (4.5-10.3) 7.2 (5.4-9.6) 8.0 (5.8-10.9) 
Marital status       
Married and living with partner 3.4 (2.5-4.8) 2.7 (2.0-3.5) 5.5 (4.4-6.9) 6.2 (4.8-8.0) 6.7 (5.4-8.2) 7.9 (6.7-9.4) 
Separated, divorced, widowed, or 
single 5.3 (3.7-7.4) 5.3 (3,8-7.3) 6.9 (5.2-9.2) 15.0 (11.7-18.9) 9.9 (7.9-12.2) 12.9 (10.7-15.5) 
Social support       
Poor 7.1 (4.3-11.4) 6.1 (4.0-9.2) 16.1 (12.0-21.2) 22.6 (15.6-31.5) 17.6 (13.4-22.7) 27.7 (22.7-33.2) 
Moderate 3.6 (2.5-5.2) 3.3 (2.4-4.4) 5.3 (4.2-6.7) 8.7 (6.8-11.1) 6.7 (5.4-8.2) 8.8 (7.2-10.8) 
Strong 4.1 (2.6-6.2) 3.3 (2.0-5.5) 4.0 (2.7-5.8) 7.4 (5.2-10.4) 6.4 (4.9-8.2) 6.7 (5.1-8.7) 
Socioeconomic status       
Low  5.5 (3.1-9.7) 3.7 (2.1-6.4) 10.7 (7.8-14.6) 14.9 (10.3-21.1) 12.5 (9.4-16.5) 16.7 (13.4-20.7) 
Middle 4.4 (3.2-5.9) 3.6 (2.7-4.8) 5.4 (4.3-6.7) 8.8 (7.0-11.1) 7.1 (5.9-8.6) 9.7 (8.1-11.5) 
High 2.6 (1.5-4.8) 3.7 (2.4-5.7) 4.4 (3.0-6.4) 8.1 (5.4-12.1) 5.6 (3.8-8.2) 5.0 (3.5-7.1) 
Community size       
Rural (< 5000 inhabitants)  4.8 (2.7-8.3) 3.5 (1.6-7.4) 4.6 (3.3-6.3) 6.8 (4.5-10.0) 8.0 (5.7-10.9) 10.3 (8.0-13.2) 
Small town (5000-<20,000)  2.7 (1.4-5.1) 2.5 (1.5-4.1) 4.2 (2.9-6.1) 8.1 (5.5-11.7) 6.4 (4.6-8.7) 7.4 (5.9-9.3) 
Mid-sized town (20,000-<100,000)  5.0 (3.4-7.2) 4.1 (3.0-5.7) 7.1 (5.5-9.2) 10.5 (7.8-14.0) 6.9 (5.4-8.9) 10.8 (8.7-13.5) 





Table 4 Associations between socioeconomic status and community size (independent variables) and 12-month CIDI-defined major depressive 
disorder (CIDI-MDD), self-reported diagnosed depression in the last 12 months and current depressive symptoms (PHQ-9 ≥10) in the last 2 weeks 
(dependent variables) 
 Men  Women  
 adjusted ORa (95%-CI) p adjusted ORa (95%-CI) p 
CIDI-MDD (12 months)     
Socioeconomic status     
Low  1.8 (0.7-4.4) 0.2 1.7 (0.9-3.3) 0.1 
Middle 1.6 (0.8-3.0) 0.2 1.0 (0.6-1.7) 0.9 
High Ref.  Ref.  
Community size     
Rural (< 5000 inhabitants)  1.7 (0.7-4.1) 0.2 1.0 (0.5-1.7) 0.9 
Small town (5000-<20,000)  Ref.  Ref.  
Mid-sized town (20,000-<100,000)  1.9 (0.9-4.1) 0.1 1.4 (0.8-2.4) 0.3 
Large town (≥100,000) 1.5 (0.7-3.4) 0.3 1.4 (0.8-2.4) 0.3 
Self-reported diagnosed depression (12 months)     
Socioeconomic status     
Low  0.9 (0.4-2.0) 0.8 2.1 (1.3-3.4) 0.002 
Middle 1.0 (0.5-1.8) 0.9 1.2 (0.7-1.8) 0.5 
High Ref.  Ref.  
Community size     
Rural (< 5000 inhabitants)  1.6 (0.7-4.0) 0.3 1.2 (0.8-2.0) 0.4 
Small town (5000-<20,000)  Ref.  Ref.  
Mid-sized town (20,000-<100,000)  2.0 (1.1-3.8) 0.03 1.1 (0.7-1.8) 0.6 
Large town (≥100,000) 2.2 (1.2-4.1) 0.02 1.5 (1.0-2.5) 0.07 
Current depressive symptoms (2 weeks)     
Socioeconomic status     
Low  2.1 (1.2-3.8) 0.008 3.0 (1.9-4.6) <0.001 
Middle 1.2 (0.8-1.8) 0.5 1.8 (1.2-2.8) 0.009 
High Ref.  Ref.  
Community size     
Rural (< 5000 inhabitants)  1.0 (0.6-1.8) 0.9 1.5 (1.0-2.1) 0.05 
Small town (5000-<20,000)  Ref.  Ref.  
Mid-sized town (20,000-<100,000)  1.7 (1.0-2.7) 0.04 1.6 (1.1-2.3) 0.02 
Large town (≥100,000) 1.6 (0.9-2.7) 0.09 1.5 (1.0-2.4) 0.06 
a OR: odds ratio, adjusted for age group, socioeconomic status, community size, marital status, social support, number of chronic somatic conditions. Categories 
with the lowest prevalence were defined as reference categories. 
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Table 5 Regression analyses examining associations between 12-month CIDI-defined major depressive disorder (CIDI-MDD), self-reported 
diagnosed depression in the last 12 months and current depressive symptoms (PHQ-9 ≥10) in the last 2 weeks (independent variables) and 
health-related correlates (dependent variables) 
 Men Women 









CIDI-MDD (12 months)           
Poor/fair self-rated health, % 14.4 38.7 OR 2.9 (1.3-6.4) 0.01 14.7 40.0 OR 4.5 (2.5-7.9) <0.001 
No. of chronic somatic 
conditions, % 
          
1 21.1 20.8 RRR 1.5 (0.7-3.1) 0.3 21.0 20.3 RRR 1.3 (0.8-2.2) 0.3 
2+ 25.2 34.9 RRR 2.8 (1.2-6.8) 0.02 27.2 19.4 RRR 1.3 (0.8-2.4) 0.3 
SF-36 physical functioning 
scale, mean 
89.3 80.2 ß -7.5 (-13.5 to -1.5) 0.02 85.1 78.2 ß -6.9 (-11.7 to -2.1) 0.005 
SF-36 social functioning scale, 
mean 
89.7 61.5 ß -26.2 (-33.7 to -18.7) <0.001 86.3 65.5 ß -18.4 (-23.3 to -13.5) <0.001 
Any activity limitation days due 
to physical or mental health 
problems (4 weeks), % 
35.6 67.8 OR 2.9 (1.6-5.2) 0.001 43.7 76.3 OR 3.3 (2.0-5.2) <0.001 
No. of activity limitation days 
due to physical or mental health 
problems (4 weeks), mean 
2.3 7.1 IRR* 2.0 (1.3-3.2) 0.004 2.7 9.0 IRR* 1.9 (1.5-2.4) <0.001 
Any sick leave days (12 
months) a, % 
56.1 72.3 OR 1.6 (0.7-3.7) 0.3 58.6 66.2 OR 1.0 (0.5-1.7) 0.9 
No. of sick leave days (12 
months) a, mean 
10.5 21.7 IRR* 1.9 (1.1-3.2) 0.01 11.8 18.9 IRR* 1.6 (1.0-2.6) 0.06 
Any hospital admission (12 
months), % 
11.4 23.9 OR 2.1 (1.1-4.2) 0.03 13.7 10.2 OR 0.6 (0.3-1.2) 0.2 
No. of outpatient physician visits 
(12 months), mean 
6.2 14.5 IRR** 1.9 (1.5-2.6) <0.001 8.8 12.2 IRR** 1.3 (1.0-1.6) 0.04 
Self-reported diagnosed 
depression (12 months) 
          
Poor/fair self-rated health, % 12.8 56.6 OR 6.0 (3.4-10.7) <0.001 13.6 43.0 OR 3.7 (2.4-5.5) <0.001 
No. of chronic somatic 
conditions, % 
          
1 21.4 24.1 RRR 2.1 (1.0-4.6) 0.05 22.2 27.5 RRR 1.8 (1.1-2.9) 0.01 
2+ 24.1 44.3 RRR 3.3 (1.6-7.0) 0.002 25.3 37.7 RRR 2.4 (1.5-3.8) 0.001 
SF-36 physical functioning 
scale, mean 
89.4 72.1 ß -13.0 (-18.6 to -7.3) <0.001 85.5 72.5 ß -8.1 (-11.9 to -4.3) <0.001 
SF-36 social functioning scale, 89.4 57.8 ß -29.5 (-34.9 to -24.1) <0.001 86.0 61.5 ß -21.9 (-26.2 to -17.6) <0.001 
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 Men Women 










Any sick leave days (12 
months) a , % 
55.5 69.4 OR 1.8 (0.9-3.5) 0.1 58.8 76.3 OR 2.0 (1.2-3.5) 0.01 
No. of sick leave days (12 
months) a mean 
9.6 31.8 IRR* 2.3 (1.5-3.5) <0.001 9.6 45.4 IRR* 3.2 (2.2-4.5) <0.001 
Any hospital admission (12 
months), % 
11.6 30.1 OR 1.9 (1.0-3.6) 0.04 12.7 21.3 OR 1.4 (0.9-2.1) 0.1 
No. of outpatient physician visits 
(12 months), mean 
6.0 17.0 IRR** 2.5 (1.8-3.5) <0.001 8.3 19.5 IRR** 2.0 (1.7-2.4) <0.001 
Current depressive 
symptoms (2 weeks) 
          
Poor/fair self-rated health, % 11.8 53.2 OR 8.6 (5.2-14.5) <0.001 11.8 47.4 OR 5.3 (3.6-7.8) <0.001 
No. of chronic somatic 
conditions, % 
          
1  21.3 24.0 RRR 2.3 (1.3-4.1) 0.004 22.6 20.8 RRR 1.6 (1.0-2.3) 0.03 
2+ 23.8 35.2 RRR 4.0 (2.0-7.6) <0.001 24.6 32.0 RRR 2.7 (1.7-4.1) <0.001 
SF-36 physical functioning 
scale, mean 
89.7 74.7 ß -12.5 (-16.4 to -8.6) <0.001 86.2 71.8 ß -11.7 (-14.9 to -8.5) <0.001 
SF-36 social functioning scale, 
mean 
90.5 53.5 ß -34.8 (-39.5 to -30.1) <0.001 87.6 56.0 ß -28.8 (-32.3 to -25.4) <0.001 
Any sick leave days (12 
months) a , % 
55.2 72.1 OR 1.6 (0.9-2.9) 0.1 57.9 78.9 OR 2.0 (1.2-3.1) 0.004 
No. of sick leave days (12 
months) a  mean 
9.4 27.5 IRR* 1.4 (1.0-1.9) 0.03 10.0 32.4 IRR* 1.9 (1.3-2.6) <0.001 
Any hospital admission (12 
months), % 
11.3 28.2 OR 1.9 (1.1-3.1) 0.01 12.2 20.6 OR 1.3 (0.9-1.9) 0.2 
No. of outpatient physician visits 
(12 months), mean 
5.9 14.9 IRR** 1.9 (1.5-2.5) <0.001 8.5 15.0 IRR** 1.4 (1.2-1.7) <0.001 
a Among participants younger than 65 years in employment (DEGS1: n=2,160 men and n=2,201 women; DEGS1-MH: n=1,183 men and n=1,240 women) 
b adjusted for SES, marital status, social support, number of chronic somatic conditions (except analysis on chronic somatic conditions) 
 and physical functioning (except analyses on chronic somatic conditions and SF-36 scales). OR: odds ratio from logistic regression;  RRR: relative risk ratio from 
multinomial logistic regression;  ß: ß coefficient from linear regression;  IRR*: incidence rate ratio from negative binomial regression with zero-inflation; IRR**: 
incidence rate ratio from negative binomial regression.  
 
 
